A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
Phase of Trial: Phase II
Latest Information Update: 12 Mar 2018
At a glance
- Drugs Ajulemic acid (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- Sponsors Corbus Pharmaceuticals
- 12 Mar 2018 According to a Corbus Pharmaceuticals media release, the company expects to report top-line data by the first half of 2020.
- 14 Feb 2018 According to a Corbus Pharmaceuticals media release, the company expects the first patient to be dosed in this quarter.
- 06 Feb 2018 Status changed from planning to recruiting, according to a Corbus Pharmaceuticals media release.